Showing results (1841-1850 of 3,014) with videos related to
Sort By:
Pageof 302
Zeitschrift Fur Gastroenterologie|January 28, 2021
[Results of pancreatic surgery from the perspective of patients: a cross-sectional study of the support group "Arbeitskreis der Pankreatektomierten e. V."]Ioannis Dimopoulos, Gabriele Meyer, Saleem Ibrahim Elhabash, et al.Anticancer Research|February 19, 2002
First line combination chemotherapy with docetaxel and vinorelbine in advanced breast cancer. A phase II studyD Pectasides, M A Dimopoulos, G Aravantinos, et al.Leukemia & Lymphoma|September 17, 2004
Treatment of Waldenstrom's macroglobulinemia with rituximab: prognostic factors for response and progressionMeletios A Dimopoulos, Raymond Alexanian, Dimitra Gika, et al.Annals of Hematology|August 3, 2017
Dynamic contrast-enhanced magnetic resonance imaging parameters correlate with advanced revised-ISS and angiopoietin-1/angiopoietin-2 ratio in patients with multiple myelomaEvangelos Terpos, Dimitris Matsaridis, Vassilis Koutoulidis, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 18, 2018
Improvement in Overall Survival With Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Multiple MyelomaDavid S Siegel, Meletios A Dimopoulos, Heinz Ludwig, et al.Heart (British Cardiac Society)|July 20, 2010
Cerebrovascular accidents in adult patients with congenital heart diseaseA Hoffmann, P Chockalingam, O H Balint, et al.European Journal of Cancer (Oxford, England : 1990)|January 2, 2013
Ovarian malignant ascites-derived lymphocytes stimulated with prothymosin α or its immunoactive decapeptide lyse autologous tumour cells in vitro and retard tumour growth in SCID miceIoannis F Voutsas, Nikolaos Pistamaltzian, Marinos L Tsiatas, et al.Proteomics|May 20, 2026
Peptidomic Profiling Reveals Extracellular Matrix Remodeling Signatures Discriminative of Multiple MyelomaMaria Frantzi, Melika Ahangar, Antonia Vlahou, et al.British Journal of Haematology|April 14, 2026
Benefit of selinexor dose reduction on outcomes with selinexor, bortezomib and dexamethasone in patients with lenalidomide-refractory multiple myeloma: Subgroup analysis of the BOSTON trialSosana Delimpasi, Ivan Špička, Jason P Butler, et al.Journal of the American Geriatrics Society|January 31, 2014
Critically ill elderly adults with infection: analysis of the extended prevalence of infection in intensive care studyGeorge Dimopoulos, Despoina Koulenti, Stijn Blot, et al.Pageof 302